HNRG vs. CERE, CNX, HCC, ARCH, METC, AREC, CEIX, BORR, PUMP, and PDS
Should you be buying Hallador Energy stock or one of its competitors? The main competitors of Hallador Energy include Cerevel Therapeutics (CERE), CNX Resources (CNX), Warrior Met Coal (HCC), Arch Resources (ARCH), Ramaco Resources (METC), American Resources (AREC), CONSOL Energy (CEIX), Borr Drilling (BORR), ProPetro (PUMP), and Precision Drilling (PDS).
Hallador Energy (NASDAQ:HNRG) and Cerevel Therapeutics (NASDAQ:CERE) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, community ranking, valuation and institutional ownership.
In the previous week, Cerevel Therapeutics had 3 more articles in the media than Hallador Energy. MarketBeat recorded 7 mentions for Cerevel Therapeutics and 4 mentions for Hallador Energy. Hallador Energy's average media sentiment score of 0.86 beat Cerevel Therapeutics' score of 0.85 indicating that Hallador Energy is being referred to more favorably in the media.
Hallador Energy has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500. Comparatively, Cerevel Therapeutics has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500.
Hallador Energy presently has a consensus target price of $11.00, suggesting a potential upside of 52.78%. Cerevel Therapeutics has a consensus target price of $42.67, suggesting a potential upside of 4.52%. Given Hallador Energy's higher probable upside, equities analysts clearly believe Hallador Energy is more favorable than Cerevel Therapeutics.
Hallador Energy received 86 more outperform votes than Cerevel Therapeutics when rated by MarketBeat users. However, 66.52% of users gave Cerevel Therapeutics an outperform vote while only 60.40% of users gave Hallador Energy an outperform vote.
Hallador Energy has higher revenue and earnings than Cerevel Therapeutics.
61.4% of Hallador Energy shares are held by institutional investors. Comparatively, 87.7% of Cerevel Therapeutics shares are held by institutional investors. 32.3% of Hallador Energy shares are held by insiders. Comparatively, 5.1% of Cerevel Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Hallador Energy has a net margin of 3.79% compared to Cerevel Therapeutics' net margin of 0.00%. Hallador Energy's return on equity of 8.49% beat Cerevel Therapeutics' return on equity.
Summary
Hallador Energy beats Cerevel Therapeutics on 9 of the 15 factors compared between the two stocks.
Get Hallador Energy News Delivered to You Automatically
Sign up to receive the latest news and ratings for HNRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HNRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Hallador Energy Competitors List
Related Companies and Tools
